Company profile
IO Biotech
Break Boundaries. Ignite Change.
- Industry
- Biotechnology Research
- Employees
- 34
- Headquarters
- Copenhagen, Denmark
- Founded
- 2015
- LinkedIn followers
- 10,011
- Office locations
- 1
IO Biotech company summary
IO Biotech is a company in the Biotechnology Research industry, headquartered in Copenhagen, Denmark, founded in 2015. On LinkedIn the company has around 34 employees and 10,011 followers. Its listed specialties include Cancer Vaccines and Immuno-oncology.
What technology does IO Biotech use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About IO Biotech
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field and a world-class advisory board.
Specialties
Where is IO Biotech located?
IO Biotech lists 1 location.
Compare companies similar to IO Biotech
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
IO Biotech iobiotech.com | Biotechnology Research | 34 | 2015 | Copenhagen, Denmark |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about IO Biotech
What does IO Biotech do?
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field and a world-class advisory board.
How many employees does IO Biotech have?
IO Biotech has around 34 employees on LinkedIn.
Where is IO Biotech headquartered?
IO Biotech is headquartered in Copenhagen, Denmark.
When was IO Biotech founded?
IO Biotech was founded in 2015.
Build a lead list from companies like IO Biotech
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.